📢 Key Milestones (2025-2026):
In 2025, 3M reported $24.9 billion in GAAP sales with adjusted EPS growth of 10% to $8.06. The company settled New Jersey PFAS claims for up to $450 million over 25 years (recording a $285 million pre-tax charge in Q2 2025), adding to the previously announced $10.3 billion nationwide public water system settlement. 3M completed cessation of all PFAS manufacturing by the end of 2025, fulfilling its 2022 commitment. Q1 2026 earnings are scheduled for release on April 21, 2026, with analyst consensus EPS of $1.99-$2.02. The company provided 2026 guidance for adjusted sales growth of ~4% and adjusted EPS of $8.50 to $8.70.
Company Overview (Updated April 2026)
3M Company (NYSE: MMM) is a diversified global Science and technology enterprise headquartered in St. Paul, Minnesota. Originally founded as Minnesota Mining and Manufacturing Company in 1902, 3M has evolved into a leading innovator in materials science, applying science in collaborative ways to improve lives daily. The company operates through three major business segments following the April 2024 spin-off of its Healthcare business as Solventum (NYSE: SOLV).
3M is renowned for its innovation culture, holding over 118,000 patents and producing thoUSAnds of products ranging from adhesives and abrasives to advanced materials, safety equipment, and consumer goods. The company's products are sold in nearly 200 countries, serving customers in hospitals, schools, offices, and homes worldwide.
Corporate History
- 1902: Founded as Minnesota Mining and Manufacturing Company in Two Harbors, Minnesota, initially mining corundum for sandpaper
- 1930s-1940s: Introduced Scotch® Tape and launched major diversification into chemicals and adhesives
- 1960s-1970s: Expanded into pharmaceuticals, medical products, and electronics; introduced Post-it® Notes (1980)
- 1990s-2000s: Global expansion accelerated; entered healthcare, safety, and industrial markets worldwide
- 2019-2023: Mike Roman served as CEO; navigated COVID-19 pandemic demand for respiratory protection
- 2023-Present: William Brown serves as Chairman and CEO, focusing on portfolio optimization and operational excellence
- April 1, 2024: Completed spin-off of 3M Health Care into independent publicly traded company Solventum (NYSE: SOLV)
- December 2025: Completed cessation of all PFAS manufacturing, fulfilling 2022 commitment
Business Segments (Current Structure)
Safety and Industrial (46% of 2025 Sales: $11,384M)
Provides industrial abrasives and finishing for metalworking, autobody repair solutions, structural adhesives and tapes, electrical products and materials for construction and maintenance, power distribution, and electrical OEMs. Includes personal safety products such as respiratory protection, hearing protection, eye and fall protection solutions, as well as natural and color-coated mineral granules for shingles. Organic sales increased 3.2% in 2025.
Transportation and Electronics (33% of 2025 Sales: $8,272M)
Serves automotive, aerospace, electronics, and transportation markets with advanced materials, adhesives, and electronic components. The segment provides solutions for vehicle lightweighting, electronics miniaturization, and advanced manufacturing. Impacted by PFAS exit restructuring actions in 2023-2025 affecting approximately 1,200 positions.
Consumer (20% of 2025 Sales: $4,920M)
Offers a wide range of consumer products including Post-it® Notes, Scotch® Tape, Scotch-Brite® cleaning products, Command™ adhesive hooks, and Filtrete™ air filters. These products are sold through retail channels and e-commerce platforms worldwide.
Financial Performance (FY 2025)
Full Year Results
- GAAP Sales: $24.9 billion, up 1.5% year-over-year
- Adjusted Sales: $24.3 billion, up 2.7% year-over-year with organic growth of 2.1%
- GAAP EPS: $6.00, down 17% YoY (reflecting litigation and transformation costs)
- Adjusted EPS: $8.06, up 10% year-over-year
- GAAP Operating Income Margin: 18.6%
- Adjusted Operating Income Margin: 23.4%, up 200 basis points YoY
- Operating Cash Flow: $2.3 billion
- Adjusted Free Cash Flow: $4.4 billion
- Shareholder Returns: $4.8 billion via dividends and share repurchases
- Employee Count: Approximately 46,000 (post-Solventum spin-off)
Q4 2025 Highlights
- GAAP Sales: $6.1 billion, up 2.1% YoY; organic sales up 0.6%
- Adjusted Sales: $6.0 billion, up 3.7% YoY; adjusted organic sales up 2.2%
- Adjusted EPS: $1.83, up 9% year-over-year (beat analyst estimate of $1.81 by 1.10%)
- Adjusted Operating Margin: 21.1%, up 140 basis points YoY
- Operating Cash Flow: $1.6 billion
- Adjusted Free Cash Flow: $1.3 billion
Q1 2026 Preview (Scheduled April 21, 2026)
- Expected Report Date: April 21, 2026
- Analyst Consensus EPS: $1.99-$2.02 (vs. $1.68 in Q1 2025)
2026 Financial Guidance
- Adjusted Total Sales Growth: ~4%, reflecting adjusted organic sales growth of ~3%
- Adjusted Operating Income Margin Expansion: 70-80 basis points
- Adjusted EPS: $8.50 to $8.70
- Adjusted Operating Cash Flow: $5.6 to $5.8 billion, contributing to >100% adjusted free cash flow conversion
- Adjusted Effective Tax Rate: ~20%
- Capital Expenditures (PPE): ~$1.1 billion
- Adjusted Free Cash Flow: $4.6 to $4.8 billion
PFAS Litigation and Environmental Settlements
Nationwide Public Water System Settlement: In 2023, 3M agreed to a $10.3 billion settlement over 13 years to resolve claims related to PFAS contamination in public water systems across the United States.
New Jersey State Settlement (May 12, 2025): 3M agreed to pay up to $450 million over 25 years to resolve PFAS-related claims with the State of New Jersey, including:
- $275-325 million for natural resource damages and PFAS abatement (2026-2034)
- $125 million for statewide remediation (2035-2050)
- $40 million for legal costs and punitive damages (first year)
- $50-100 million recognizing New Jersey's leadership in PFAS abatement (2027-2029)
3M recorded a pre-tax charge of approximately $285 million in Q2 2025 for this settlement ($210 million for Chambers Works and other elements, $75 million for existing and future claims).
Minnesota Settlement (2018): $850 million settlement with the State of Minnesota for PFAS contamination in the Twin Cities east metropolitan area, with approximately $720 million invested in drinking water and natural resource projects.
PFAS Manufacturing Cessation: By the end of 2025, 3M completed its exit of all PFAS (per- and polyfluoroalkyl substances) manufacturing, fulfilling a commitment first announced in December 2022. The company has removed PFAS from approximately 7,000 products (about one-third of its portfolio) over the past three years.
Innovation and Research
3M operates a robust research and development program with R&D expenses of $1.17 billion in 2025. The company maintains a global network of laboratories and technical centers, focusing on:
- Advanced materials and adhesives
- Industrial automation and manufacturing technologies
- Personal protective equipment innovation
- Sustainability solutions including water quality, air filtration, and renewable energy materials
- Digital transformation and data analytics capabilities
Leadership
William Brown – Chairman and Chief Executive Officer (since May 2023)
- Previously served as CEO of L3Harris Technologies
- Focused on reshaping operating model, driving sustainable value creation, and operational excellence
Key Executives:
- Senior Vice President and Chief Financial Officer: Theresa Reishus
- Executive Vice President, Safety and Industrial: Jeff Lavers
- Executive Vice President, Transportation and Electronics: Ashish K. Khandpur
- Executive Vice President, Consumer: Kristen Ludgate
Corporate Information
Legal Name: 3M Company (formerly Minnesota Mining and Manufacturing Company)
Founded: 1902
Headquarters: St. Paul, Minnesota, USA
Stock Ticker: MMM (NYSE)
Website: www.3m.com
Investor Relations: investors.3m.com
Employees: Approximately 46,000 (post-Solventum spin-off)
Patents: Over 118,000 patents held globally
Countries Served: Nearly 200
Strategic Priorities and Outlook
Under CEO William Brown's leadership, 3M is focused on:
- Actively managing the business portfolio to drive growth faster than the markets and economies served
- Investing capital in high-growth, high-return end-markets leveraging 3M's material science strengths
- Accelerating digital capabilities and expanding data analytics to improve customer service and operational agility
- Advancing sustainability commitments including greenhouse gas emission reduction, water quality improvement, and decreased dependence on virgin fossil-based plastic
- Maintaining strong balance sheet and generating robust cash flow to support growth investments, productivity, sustainability, and shareholder returns
Contact Information
Corporate Headquarters:
3M Center
St. Paul, MN 55144
United States
Media Contact: media@3m.com
Investor Contact: investors@3m.com
Keywords: 3M Company, MMM, Minnesota Mining and Manufacturing, St. Paul, William Brown, Safety and Industrial, Transportation and Electronics, Consumer, Solventum, PFAS, forever chemicals, litigation settlement, $10.3 billion, New Jersey settlement, $450 million, $285 million pre-tax charge, 2025 financial results, 2026 guidance, $24.9 billion revenue, $8.06 adjusted EPS, $8.50-$8.70 2026 EPS guidance, material science, innovation, industrial abrasives, respiratory protection, Scotch Tape, Post-it Notes, PFAS cessation, end of 2025, Q1 2026 earnings, April 21 2026
猜你喜欢
-
3R - Industria e Comercio Ltda - Brazilian Manufacturer of Dental and Veterinary Products
3R - Industria e Comercio Ltda is a Brazilian limited... -
3M ESPE Dental Products (Now Solventum Dental Solutions) - Global Leader in Dental and Orthodontic S
3M ESPE Dental Products, formerly the dental division... -
3M Deutschland GmbH - German Subsidiary of 3M Company Driving Innovation in Materials Science
3M Deutschland GmbH is the German subsidiary of 3M Com... -
3M Company - Global Science and Technology Conglomerate in Materials Science Innovation
3M Company (NYSE: MMM) is a diversified global science and t... -
AliveCor, Inc. - Pioneer in AI-Powered Personal ECG Technology and Cardiac Care Solutions
AliveCor, Inc. is a pioneering health technology company hea... -
Cardinal Health 200, LLC - Premier Medical Device Distribution and Healthcare Supply Chain Subsidiar
Abstract: Cardinal Health 200, LLC is a wholly-owned s... -
CareDx, Inc.(凯达公司)- Global Leader in Transplant Diagnostics and Precision Medicine
CareDx, Inc. (NASDAQ: CDNA) is a leading precision medicine... -
Virax Biolabs Group Limited - T-Cell Immune Response Diagnostics Innovator
Virax Biolabs Group Limited is a biotechnology company found... -
Co-Diagnostics, Inc. - Molecular Diagnostics Platform Pioneer
Co-Diagnostics, Inc. is a molecular diagnostics company foun... -
Nyxoah SA - Leadless Hypoglossal Neurostimulation Pioneer for Obstructive Sleep Apnea
Nyxoah SA is a clinical-stage medical technology company fou... -
Zhimai (Shanghai) Robot Co., Ltd. - China's First Commercialized Coronary Vascular Intervention Surg
Zhimai (Shanghai) Robot Co., Ltd. is a medical device compan... -
Shenzhen Mindray Bio-Medical Electronics Co.,Ltd - Global Medical Device Innovation Leader
Shenzhen Mindray Bio-Medical Electronics Co.,Ltd is a...
网友评论
- 热门标签
-
- USA
- California
- China
- Korea
- Germany
- France
- Shanghai
- Florida
- New York
- 3M
- Zhejiang
- Arizona
- Tokyo
- Ireland
- Japan
- SynCardia
- Fujirebio
- Minnesota
- Canada
- British Columbia
- Ningbo
- Munich
- Illinois
- Seoul
- Michigan
- Israel
- Massachusetts
- Guangdong
- Johnson
- Mentor
- Medtronic
- Jiecheng
- Robocath
- Zhimai
- MicroPort
- Mont-Saint-Guibert
- Belgium
- Nyxoah
- Colorado
- Foresight
- Xomed
- Suzhou
- 迪泰医学
- jiangsu
- china
- Genesis
- AliveCor
- South Holland
- Netherlands
- Curatia
- 关注我们
-

扫一扫二维码关注我们的微信公众号


